Back to AVTX

Avalo Therapeutics, Inc. 8-K

Accession 0001628280-20-004223

Filing information

CIK
0001534120
Report date
2020-03-25
Filing date
2020-03-27
Form
8-K
Primary document
a8-kcaliasresignationxmarc.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.